Site Activity
This page provides a monthly listing of publication activity on the Medical Policy Portal including Policy Notifications, New Policies, Updated Policies, Coding Updates, Reissued Policies, and Archived Policies. To view publication activity from prior months, select Past Site Activity.

Past Site Activity
 
                                                                                                        

Notifications
The following Independence Blue Cross Medicare Advantage policies have been posted prior to their effective date.
MA11.099a, Septoplasty, Rhinoplasty, and Septorhinoplasty
Notification: 07/12/2017 | Effective: 10/10/2017 | Posted: 07/12/2017
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria; Medical Coding

MA08.088, Ocrelizumab (Ocrevus™)
Notification: 07/24/2017 | Effective: 08/23/2017 | Posted: 07/24/2017
Type of policy change: This is a new policy.

MA05.054d, Urological Supplies
Notification: 07/25/2017 | Effective: 08/25/2017 | Posted: 07/26/2017
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria; Medical Coding


Updated Policies
The following Medicare Advantage policies have been reviewed and updated to communicate current coverage and/or reimbursement positions, reporting requirements, and other procedures for doing business with Independence Blue Cross.
MA11.073a, Panniculectomy, Abdominoplasty, Abdominal Lipectomy, and Other Excisions of Redundant Skin
Notification: 06/07/2017 | Effective: 07/07/2017 | Posted: 07/07/2017
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

MA08.070b, Golimumab (Simponi® Aria™) Intravenous (IV) Injection
Effective: 07/12/2017 | Posted: 07/12/2017
Type of policy change: Medical Necessity Criteria; General Description, Guidelines, or Informational Update

MA08.054b, Cabazitaxel (Jevtana®)
Effective: 07/12/2017 | Posted: 07/12/2017
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria

MA08.064a, Omacetaxine Mepesuccinate (Synribo®)
Effective: 07/12/2017 | Posted: 07/12/2017
Type of policy change: Medical Necessity Criteria; General Description, Guidelines, or Informational Update

MA05.053e, Implantable and External Infusion Pumps
Notification: 06/14/2017 | Effective: 07/14/2017 | Posted: 07/14/2017
Type of policy change: Coverage and/or Reimbursement Position; Medical Coding; General Description, Guidelines, or Informational Update

MA07.007b, Pulmonary Function Tests
Notification: 06/14/2017 | Effective: 07/14/2017 | Posted: 07/14/2017
Type of policy change: Medical Coding

MA11.006b, Bronchial Thermoplasty
Effective: 07/14/2017 | Posted: 07/18/2017
Type of policy change: Medical Necessity Criteria; Medical Coding

MA00.005j, Experimental/Investigational Services
Notification: 04/19/2017 | Effective: 07/18/2017 | Posted: 07/18/2017
Type of policy change: Coverage and/or Reimbursement Position

MA05.004b, Pneumatic Compression Therapy Devices
Notification: 06/28/2017 | Effective: 07/28/2017 | Posted: 07/28/2017
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria; General Description, Guidelines, or Informational Update

MA05.003c, Speech and Non-Speech Generating Devices
Notification: 06/28/2017 | Effective: 07/28/2017 | Posted: 07/28/2017
Type of policy change: Medical Necessity Criteria


Reissue Policies
The following Medicare Advantage policies have been reviewed, and no substantive changes were made.
MA07.043, Smell and Taste Dysfunction Testing
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA10.004c, Chiropractic Services
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA10.001, Pulmonary Rehabilitation Services
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA11.101, Nucleoplasty
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA11.060a, Catheter Ablation of Cardiac Arrhythmias
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA07.001a, Hyperbaric Oxygen Therapy
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA11.061a, Transcoronary Ablation of Septal Hypertrophy (TASH)
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA10.002a, Cardiac Rehabilitation (CR) and Intensive Cardiac Rehabilitation (ICR) Programs
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA11.003, Lung Volume Reduction Surgery (LVRS)
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA07.012a, External Counterpulsation (ECP)
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA11.052, Radiofrequency Ablation and Cryosurgical Ablation of Lung Tumors
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA11.107a, Implantable Steroid-Eluting Sinus Stents
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA05.053d, Implantable and External Infusion Pumps
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA07.052, Bioimpedance for the Detection of Lymphedema
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA07.042, Complete Decongestive Therapy (CDT)
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA07.023b, Upper Gastrointestinal Endoscopy (Diagnostic and Therapeutic)
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA09.015, Positron Emission Mammography (PEM)
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA09.013a, Screening for Vertebral Fracture with Dual-Energy X-ray Absorptiometry (DEXA/DXA)
Reissue Effective: 07/10/2017 | Reissue Posted: 07/10/2017

MA00.036b, Remote Patient Management: Telemedicine Services
Reissue Effective: 07/12/2017 | Reissue Posted: 07/12/2017

MA08.034a, Enzyme Replacement Therapy for Mucopolysaccharidosis (e.g. Aldurazyme®, Elaprase™, Vimizim™, Naglazyme®, etc.)
Reissue Effective: 07/12/2017 | Reissue Posted: 07/12/2017

MA08.050, Alpha 1-Antitrypsin Therapy (e.g., Prolastin-C®, Aralast NP™, Glassia™, Zemaira™)
Reissue Effective: 07/13/2017 | Reissue Posted: 07/13/2017

MA08.057a, Belimumab (Benlysta®)
Reissue Effective: 07/13/2017 | Reissue Posted: 07/13/2017

MA08.085, Asparaginase Erwinia Chrysanthemi (Erwinaze®)
Reissue Effective: 07/13/2017 | Reissue Posted: 07/13/2017
Type of policy change: This is a new policy.

MA08.077b, Talimogene laherparepvec (Imlygic™)
Reissue Effective: 07/13/2017 | Reissue Posted: 07/13/2017
Type of policy change: Medical Necessity Criteria; Medical Coding

MA00.038a, Marijuana for Medical Use
Reissue Effective: 07/13/2017 | Reissue Posted: 07/13/2017

MA08.023a, Enzyme Replacement for the Treatment of Gaucher's Disease
Reissue Effective: 07/19/2017 | Reissue Posted: 07/19/2017

MA06.011a, Human Immunodeficiency Virus (HIV) Genotyping and Phenotyping
Reissue Effective: 07/31/2017 | Reissue Posted: 07/31/2017

MA06.012b, Genetic Testing for Inherited Susceptibility to Colon Cancer and Microsatellite Instability Testing (Familial Adenomatous Polyposis and Lynch Syndrome)
Reissue Effective: 07/31/2017 | Reissue Posted: 07/31/2017


Coding Update
The following Medicare Advantage policies have been reviewed and updated to add new and revised medical codes (e.g., ICD-9 and ICD-10 diagnosis codes; CPT® and HCPCS codes; revenue codes) and/or remove terminated medical codes.
MA12.001c, Complementary and Integrative Health Services
Effective: 07/01/2017 | Posted: 07/07/2017

MA09.021b, Magnetic Resonance Imaging (MRI)-Guided Focused Ultrasound Ablation
Effective: 07/01/2017 | Posted: 07/10/2017










Connect with Us        


© 2017 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.